PO.TB10.12 · 肿瘤生物学

ECM硬度和谷氨酰胺可用性在胰腺癌与癌相关成纤维细胞的3D共培养模型中重塑代谢和免疫表型

ECM stiffness and glutamine availability rewire metabolic and immune phenotypes in 3D Co-culture models of pancreatic cancer and cancer-associated fibroblasts

编号 771 展板 16 时间 4/19 02:00–05:00 区域 Section 31 主讲 Jonathan Barajas, BA
分会场 Physicochemical Modulation of Cancer Ecosystems: Mechanical Forces, Hypoxia, and Acidosis
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Jonathan Barajas1, Carolyn Ruiz1, Zhi Yang1, Bo Han1, Edward Agyare2, Xueyou Zhu2, Saun-Joo Yoon3

1USC - University of Southern California, Los Angeles, CA,2Florida A&M University, Tallahassee, FL,3University of Florida, Gainsville, FL

摘要 Abstract

中文摘要
胰腺导管腺癌(PDAC)在富含细胞外基质(ECM)和癌相关成纤维细胞(CAFs)的致密肿瘤微环境(TME)中发展。PDAC肿瘤还高度依赖谷氨酰胺代谢。虽然ECM硬度和营养可用性各自影响肿瘤行为,但它们在3D背景下对CAF和PDAC表型的综合效应尚未明确界定。我们研究了基质硬度和谷氨酰胺补充如何调节CAF和患者来源PDAC细胞中的氧化应激、脂质代谢、线粒体、细胞结构和PD-L1表达。软(3A)和硬(6A)胶原基ECM凝胶为自制。将原代人CAF或PDAC细胞系(G43、G46)包埋于3D中,并在48小时和7天时评估。CAF采用CellROX、JC-1、BODIPY、鬼笔环肽和PD-L1染色分析。PDAC细胞在基础DMEM、谷氨酰胺补充的DMEM或类器官样培养基中培养。使用抗线粒体抗体配AF488二抗检测线粒体。所有样本均在20×放大倍数下进行3D成像。ECM硬度显著改变了CAF的氧化应激反应。在48小时时,软ECM和硬ECM中的CAF显示出可比但可检测的CellROX信号,而到7天时,硬ECM产生了氧化应激的显著增加,强CellROX阳性细胞核数量更多。荧光强度定量证实了氧化应激随时间的上升,并在硬ECM条件下被放大。这一增加与7天时JC-1 J聚集体形成升高相一致,表明线粒体极化增强。硬ECM中的CAF还表现出更强的F-actin排列、细胞铺展和脂质积累,提示对机械应激的协调性代谢和细胞骨架适应。PD-L1表达同样随时间增加,并在硬ECM中保持更高水平,支持机械感知在促进免疫逃逸型CAF表型中的作用。在PDAC细胞中,ECM硬度和营养环境共同控制代谢输出。BODIPY染色揭示了硬度依赖性的脂滴模式,该模式在类器官样培养基下进一步放大。谷氨酰胺补充增加了G43和G46中的线粒体信号强度并重组了线粒体网络,这与谷氨酰胺驱动的代谢激活一致。ECM硬度还塑造了F-actin结构和线粒体定位,表明存在生物力学-代谢的相互作用。总之,这些结果显示,ECM硬度和谷氨酰胺可用性重编程了CAF和PDAC的代谢和免疫特征。这项工作强调了在模拟PDAC时需要同时纳入力学和代谢线索,并将代谢-免疫通路确定为TME内潜在的治疗脆弱点。
查看英文原文 English abstract
Pancreatic ductal adenocarcinoma (PDAC) develops within a dense, tumor microenvironment (TME) enriched with extracellular matrix (ECM) and cancer-associated fibroblasts (CAFs). PDAC tumors also rely heavily on glutamine metabolism. While ECM stiffness and nutrient availability each influence tumor behavior, their combined effects on CAF and PDAC phenotypes in 3D contexts are not well defined. We investigated how matrix stiffness and glutamine supplementation modulate oxidative stress, lipid metabolism, mitochondria, cellular architecture, and PD-L1 expression in CAFs and patient-derived PDAC cells. Soft (3A) and stiff (6A) collagen-based ECM gels were generated in-house. Primary human CAFs or PDAC lines (G43, G46) were embedded in 3D and assessed at 48 hr and 7 days. CAFs were analyzed using CellROX, JC-1, BODIPY, phalloidin, and PD-L1 staining. PDAC cells were cultured in basal DMEM, glutamine-supplemented DMEM, or organoid-like media. Mitochondria were detected using an anti-mitochondrial antibody with AF488 secondary. All samples were imaged in 3D at 20× magnification. ECM stiffness significantly altered CAF oxidative stress responses. At 48 hr, CAFs in soft and stiff ECM showed comparable but detectable CellROX signal, whereas by 7 days, stiff ECM produced a marked increase in oxidative stress with a higher number of strongly CellROX-positive nuclei. Quantification of fluorescence intensity confirmed a time-dependent rise in oxidative stress that was amplified under stiff ECM conditions. This increase aligned with elevated JC-1 J-aggregate formation at 7 days, indicating enhanced mitochondrial polarization. CAFs in stiff ECM also exhibited greater F-actin alignment, cell spreading, and lipid accumulation, suggesting coordinated metabolic and cytoskeletal adaptation to mechanical stress. PD-L1 expression likewise increased over time and remained higher in stiff ECM, supporting a role for mechanosensing in promoting immune-evasive CAF phenotypes. In PDAC cells, ECM stiffness and nutrient environment jointly controlled metabolic outputs. BODIPY staining revealed stiffness-dependent lipid droplet patterns, which were further amplified by organoid-like media. Glutamine supplementation increased mitochondrial signal intensity and reorganized mitochondrial networks in both G43 and G46, consistent with glutamine-driven metabolic activation. ECM stiffness also shaped F-actin architecture and mitochondrial localization, indicating a biomechanical-metabolic interaction. Together, these results show that ECM stiffness and glutamine availability reprogram CAF and PDAC metabolic and immune features. This work underscores the need to incorporate both mechanical and metabolic cues when modeling PDAC and identifies metabolic-immune pathways as potential therapeutic vulnerabilities within the TME.
利益披露 Disclosure
J. Barajas, None.. C. Ruiz, None.. Z. Yang, None.. B. Han, None.. E. Agyare, None.. X. Zhu, None.. S. Yoon, None.

← 返回 AACR 2026 检索